CXCL13 and malignant colon neoplasm: Furthermore, when colon cancer cells were endoscopically injected into the colon submucosa, CXCL13 injection reduced tumor formation, whereas the deficiency in CXCR5 gene, a receptor for CXCL13, accentuated tumor formation [19].